within Pharmacolibrary.Drugs.ATC.V;

model V04CX03
  extends Pharmacokinetic.Models.PK_1C(
    weight         = 70,
    F              = 1,
    Cl             = 0.0016666666666666668,
    adminDuration  = 600,
    adminMass      = 200 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.0002,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>V04CX03</td></tr><td>route:</td><td>inhalation</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Methacholine is a synthetic choline ester that acts as a non-selective muscarinic receptor agonist. It is primarily used in the diagnosis of bronchial hyperreactivity (asthma) in the form of a methacholine challenge test. Methacholine is not used as a therapeutic drug; its approved use is in diagnostic procedures.</p><h4>Pharmacokinetics</h4><p>No direct human pharmacokinetic data published; estimates based on available limited animal and in vitro data. Methacholine exhibits rapid metabolism by cholinesterases and an extremely short plasma half-life. Typically administered via inhalation during bronchoprovocation challenge tests.</p><h4>References</h4><ol><li><p>Ormrod, D, &amp; Spencer, CM (1999). Levosalbutamol. <i>BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy</i> 11(6) 431–438. DOI:<a href=&quot;https://doi.org/10.2165/00063030-199911060-00007&quot;>10.2165/00063030-199911060-00007</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/18031154/&quot;>https://pubmed.ncbi.nlm.nih.gov/18031154</a></p></li><li><p>Kim, WW, et al., &amp; Cho, SH (2012). Xenon-enhanced dual-energy CT of patients with asthma: dynamic ventilation changes after methacholine and salbutamol inhalation. <i>AJR. American journal of roentgenology</i> 199(5) 975–981. DOI:<a href=&quot;https://doi.org/10.2214/AJR.11.7624&quot;>10.2214/AJR.11.7624</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/23096168/&quot;>https://pubmed.ncbi.nlm.nih.gov/23096168</a></p></li><li><p>Richards, R, et al., &amp; Holgate, S (1988). Effect of methacholine induced bronchoconstriction on the pulmonary distribution and plasma pharmacokinetics of inhaled sodium cromoglycate in subjects with normal and hyperreactive airways. <i>Thorax</i> 43(8) 611–616. DOI:<a href=&quot;https://doi.org/10.1136/thx.43.8.611&quot;>10.1136/thx.43.8.611</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/3140407/&quot;>https://pubmed.ncbi.nlm.nih.gov/3140407</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end V04CX03;
